INOGEN, INC. (NASDAQ:INGN) Files An 8-K Submission of Matters to a Vote of Security Holders

ME Staff 8-k
-
0

INOGEN, INC. (NASDAQ:INGN) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders.

Inogen, Inc. (the Company) held its 2017 annual meeting of
stockholders on May 11, 2017 (the Annual Meeting).Of the
20,558,677 shares of the Companys common stock outstanding as of
the record date of March 17, 2017, 19,399,843 shares were
represented at the Annual Meeting, either in person or by proxy,
constituting approximately 94.36% of the outstanding shares of
common stock. The matters voted on at the Annual Meeting and the
votes cast with respect to each such matter are set forth below:

1.

Election of Class III Directors.The following nominees
were elected to serve as Class III directors, to hold
office until the Companys 2020 annual meeting of
stockholders or until his or her respective successor has
been duly elected and qualified:

Nominee

Votes For

Votes Withheld

Broker Non-Votes

Heath Lukatch, Ph.D.

13,123,269

4,458,845

1,817,729

Raymond Huggenberger

12,951,502

4,630,612

1,817,729

2.

Ratification of Appointment of Independent Registered
Public Accounting Firm. The appointment of Deloitte
Touche LLP as the Companys independent registered public
accounting firm for the fiscal year ending December 31,
2017 was ratified based on the following results of
voting:

Votes For

Votes Against

Abstentions

Broker Non-Votes

19,379,748

12,242

7,853

N/A

3.

Advisory Vote on Executive Compensation. The Companys
stockholders advised that they were in favor of the named
executive officers compensation as disclosed in the proxy
statement. The votes regarding the proposal were as
follows:

Votes For

Votes Against

Abstentions

Broker Non-Votes

17,147,676

418,437

16,001

1,817,729

4.

Advisory Vote on Frequency of Future Advisory Votes on
Executive Compensation. The Companys stockholders advised
that they were in favor of one year as the frequency of
holding a non-binding advisory vote on named executive
officers compensation. The votes regarding the proposal
were as follows:

1 Year

2 Years

3 Years

Abstained

Broker Non-Votes

15,038,368

145,402

2,387,744

10,600

1,817,729

In accordance with the voting results for this proposal, the
board of directors of the Company has determined that the Company
will hold future stockholder advisory votes on the compensation
of the Companys named executive officers every year. The next
required advisory vote on the frequency of future stockholder
advisory votes on the compensation of the Companys named
executive officers will take place no later than at the Companys
2023 annual meeting of stockholders.


About INOGEN, INC. (NASDAQ:INGN)

Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.

INOGEN, INC. (NASDAQ:INGN) Recent Trading Information

INOGEN, INC. (NASDAQ:INGN) closed its last trading session down -1.29 at 82.01 with 241,022 shares trading hands.